GLP2-Tirz (30mg)
Non-returnable
$310.00
GLP-1T designates a dual-receptor research compound activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, investigated for combined effects on insulin secretion, lipid handling, and adipose tissue metabolism.
Disclaimer
For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Choose Quantity
Product Details
About GLP-1T
GLP-1T designates a research compound with dual receptor activity at both the GLP-1 receptor and the GIP receptor. Dual-receptor agonism has become a significant area of metabolic research, with literature exploring whether combined activation of the two incretin pathways produces effects beyond those of single-receptor agonists.
Mechanism in Research Literature
The dual-agonist class has been documented to:
- Activate both GLP-1 and GIP receptor pathways
- Stimulate glucose-dependent insulin secretion (GLP-1 contribution)
- Modulate adipose tissue lipid handling (GIP contribution in research models)
- Affect appetite and gastric emptying via GLP-1 pathway
- Show additive effects vs. single-receptor agonists in metabolic research models
Research Context
Dual GLP-1/GIP agonists have been investigated in studies exploring:
- Combined incretin receptor pharmacology
- Adipose tissue lipid metabolism and free fatty acid handling
- Glucose homeostasis in metabolic dysfunction models
- Comparative efficacy vs. single-receptor agonists
- Lipid profile and cardiometabolic biomarker research
Related Research Peptides
GLP-1T appears in literature alongside GLP-1R and GLP-1S (single-receptor agonists), and adjacent metabolic compounds (AOD-9604, Tesamorelin, 5-Amino-1MQ, MOTS-c).
